2023
DOI: 10.1016/j.ahj.2022.10.084
|View full text |Cite
|
Sign up to set email alerts
|

Chelation trial in patients with cardiovascular disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…Its effect as an antidote was first used by Chinese researchers in 1965 [ 48 ]. Chelation testing is currently performed in patients with cardiovascular disease and in patients waiting for a kidney transplant who are exposed to lead [ 49 , 50 ]. Recent studies also show that chelation therapy with DMPS and ALA is used to alleviate behavioural deficits, inflammation, and oxidative stress caused by copper [ 51 ].…”
Section: Antidotes For Metal Intoxicationsmentioning
confidence: 99%
“…Its effect as an antidote was first used by Chinese researchers in 1965 [ 48 ]. Chelation testing is currently performed in patients with cardiovascular disease and in patients waiting for a kidney transplant who are exposed to lead [ 49 , 50 ]. Recent studies also show that chelation therapy with DMPS and ALA is used to alleviate behavioural deficits, inflammation, and oxidative stress caused by copper [ 51 ].…”
Section: Antidotes For Metal Intoxicationsmentioning
confidence: 99%